Review Article

Chinese Herbal Medicine (Weijing Decoction) Combined with Pharmacotherapy for the Treatment of Acute Exacerbations of Chronic Obstructive Pulmonary Disease

Table 1

Characteristics of included studies.

First author, publication year,
country,
setting
Treatment durationSeverity; duration of conditionNumber of participants randomised/assessedAge (mean (SD) or range);
gender (M/F)
Intervention*Control (pharmacotherapy)

Chen et al., 2008 [18],
China,
inpatients
2 wNS; I: 9.8 (5.0) y
C: 9.5 (4.6) y
I: 36/36
C: 30/30
I: 65.7 (8.3); 24/12
C: 64.8 (8.0); 18/12
Weijing decoction and Er chen decoctionRoutine care (oxygen therapy, bronchodilators, antibiotics, mucolytics plus nutritional therapy) not specified

Jing et al., 2007 [9],
China,
inpatients
1 wMild-moderate; I: 17.2 (3.5) y
C: 13.5 (3.7) y
I: 30/30
C: 30/30
I: 66.3 (5.4); 22/8
C: 67.2 (4.4); 20/10
Qian jin Weijing decoctionRoutine care (bronchodilators, antibiotics, mucolytics plus nutritional therapy) not specified

Liu et al., 2006 [22],
China,
NS
10 dI: mild-very severe; 16.86 (10.97) y
C: mild-very severe; 17.20 (11.25) y
I: 30/30
C: 30/30
I: 69.17 (7.53); 21/9
C: 69.05 (7.83); 22/8
Jia wei qian jin Weijing decoctionRoutine care (oxygen, antibiotics plus nutritional therapy) not specified

Chen and Qiu, 2012 [17],
China,
inpatients
2 wI: NS; 16.79 (10.53) y/
C: NS; 17.20 (11.25) y
I: 30/30
C: 30/30
I: 72.07 (8.39); 20/10
C: 71.05 (7.93); 22/8
Qian jin Weijing decoctionOxygen therapy, Methylxanthines (Doxofylline 0.3 g iv qd); Ventolin 2 spray inhaled, Ipratropium 10 mL qd inhaled, Levofloxacin, 0.4 g, IV, qd; ambroxol hydrochloride, 30 mg, IV, tid;

Shi et al., 2007 [24],
China,
inpatients
2 wI: mild: 4, moderate: 29, severe: 7, 16.34 (9.53) y/
C: mild: 2, moderate: 19, severe: 9; 17.17 (10.22) y
I: 40/40
C: 30/30
I: 61.4 (6.8); 27/13
C: 59.5 (7.2); 18/12
Weijing xuan bi decoctionOxygen therapy, antibiotics (Cefmetazole 1 g iv bid) plus methylxanthines (Aminophylline 0.1 g, bid) plus mucolytic (Mucosolvan 30 mg bid)

Zhang et al., 2009 [28],
China,
inpatients
10 dNSI: 30/30
C: 30/30
I: 65.21 (6.02); 25/5
C: 65.30 (6.13); 23/7
Qian jin Weijing decoctionOxygen therapy, antibiotics plus methylxanthines (Theophylline 0.2 g, bid) plus mucolytic (Mucosolvan 30 mg tid)

Chen and Wang, 2009 [19],
China,
inpatients
15 dNSI: 31/31
C: 31/31
I: 62.5 (NS); 23/8
C: 61.7 (NS); 22/9
Weijing decoctionOxygen therapy, Cefalexin, 3 g, qd-bid; ipratropium, 2 mL, inhaled, tid; salbutamol, 1 mL, inhaled, tid; theophylline, 0.2 g, bid; Mucosolvan, 30 mg, tid

Li, 2009 [10],
China,
inpatients
10 dI: mild: 5, moderate: 25; 9.94 (3.62) y/
C: mild: 6, moderate: 24; 8.98 (3.41) y
I: 30/30
C: 30/30
I: 63.87 (8.64); 19/11
C: 63.62 (7.23); 18/12
Qian jin Weijing decoctionoxygen therapy, Levofloxacin, 0.3 g, IV, qd; salbutamol, 200 ug, inhaled tid, ipratropium, 20 ug, inhaled, tid, theophylline, 0.2 g, PO, bid; ambroxol hydrochloride, 30 mL, tid

Shi et al., 2010 [23],
China,
NS
10 dNSI: 20/20
C: 20/20
Total: 52–83; 31/9Weijing decoction and liu jun zi decoctionRoutine care (oxygen therapy, bronchodilators, antibiotics, mucolytics, and others) not specified

Jing et al., 2006 [21],
China,
inpatients
10 dmild-moderate; I: 13.2 (3.7) y
C: 12.8 (3.9) y
I: 30/30
C: 30/30
I: 64.7 (5.2); 21/9
C: 64.2 (4.9); 18/12
Qian jin Weijing decoction jia jianRoutine care (bronchodilators, antibiotics, mucolytics plus nutritional therapy) not specified

Xu, 2012 [25],
China,
out/inpatients
2 wI: NS; 12.24 (3.79) y/
C: NS; 15.29 (5.34) y
I: 40/40
C: 38/38
I: 65.82 (11.73); 23/17
C: 64.15 (13.84); 21/17
Qian jin Weijing decoction and ma xing shi gan decoctionOxygen therapy, antibiotics plus methylxanthines (Aminophylline) plus mucolytic (Mucosolvan)

Zang, 2010 [26],
China,
inpatients
2 wMild-severe; I: 11.6 (NS) d
C: 10.4 (NS) d
I: 35/35
C: 35/35
I: 62.3 (NS); 23/12
C: 61.7 (NS); 24/11
Qian jin Weijing decoction and ma xing shi gan decoctionRoutine care (bronchodilators, antibiotics, mucolytics plus nutritional therapy) not specified

Zhang, 2011 [29],
China,
NS
10 dNSI: 40/40
C: 40/40
Total: 67.7 (7.1); 59/21Qian jin Weijing decoction (modified)Routine care (oxygen therapy, bronchodilators, antibiotics, mucolytics) not specified

Zhan, 2008 [27],
China,
out/inpatients
10 dI: mild: 5, moderate: 13, severe: 12; 15.46 (8.37) y/
C: mild: 5, moderate: 15, severe: 10; 16.01 (2.68) y
I: 30/30
C: 30/30
I: 65.7 (8.54); 25/5
C: 64.9 (9.61); 23/7
Weijing decoctionOxygen therapy, Levofloxacin, 0.3 g, IV, qd methylxanthines (Aminophylline 0.1 g, bid) plus mucolytic (ambroxol, 30 mg, tid)

Guo, 2010 [20],
China,
inpatients
15 dI: NS; 8.9 y
C: NS; 9.3 y
I: 56/56
C: 44/44
I: 63.5; 30/26
C: 68.5; 21/23
Weijing decoctionOxygen therapy, antibiotics plus methylxanthines (Theophylline 0.2 g, bid) plus mucolytic (Mucosolvan 30 mg tid)

I: intervention; C: control; IV: intravenous; NS: not specified; d: day; w: week; y: year.
*In all studies the same pharmacotherapy was used in the intervention group as in the control group.